Tazorac Topical Cream 0.05pct Drug Medication Dosage Information
show timeout overlay link

Your Session Is About to Expire

This online session is about to expire due to inactivity. Click Continue to return to page.

  • myWeekly Ad

Tazorac: Topical cream (0.05%)

Also see:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics

Visit Drug Summary Page
Drug Image file default-drug-image.png
Tazorac 0.05% Topical Cream
Drug Image file default-drug-image.png
Tazorac 0.05% Topical Cream

What is this Medicine?

TAZAROTENE (ta ZAR oh teen) is applied to the skin to treat psoriasis and mild to moderate acne.

Similar Brand Name Drugs : Avage: Topical cream (0.1%)
CVS Pharmacy Patient Statistics for Tazorac: Topical cream(0.05%)
Generic vs. Brand Name Usage*
*Brand contains same active ingredient but may not represent FDA-approved generic equivalent
Usage By Strength
In-Depth Information

Tazorac 0.05% Topical Cream

NDC: 000239155
  • Prescription Required
  • Not a Controlled Drug
    (CSA Schedule)
  • FDA Approved




FDA approved for the following conditions:
Acne Vulgaris, Psoriasis

Storage Information
Store at 77 degrees F; excursions permitted to 59-86 degrees F
Tazorac 0.05% Topical Cream

Reported Side Effects for Tazorac 0.05% Topical Cream

Allergic Skin Reaction Incidence:
<10.0%*
Severity: MODERATE
Onset: DELAYED
Itching Incidence:
<30.0%*
Severity: MILD
Onset: RAPID
Skin Rash Incidence:
<10.0%*
Severity: MILD
Onset: EARLY
Skin Discoloration Incidence:
<10.0%*
Severity: MILD
Onset: DELAYED
Dry Skin Incidence:
1.0-30.0%*
Severity: MILD
Onset: DELAYED
Bleeding Incidence:
1.0-10.0%*
Severity: MODERATE
Onset: EARLY
Fluid Retention Incidence:
1.0-10.0%*
Severity: MODERATE
Onset: DELAYED
Skin Irritation Incidence:
1.0-30.0%*
Severity: MILD
Onset: EARLY
High Triglycerides Incidence:
1.1-9.9%*
Severity: MODERATE
Onset: DELAYED
Skin Redness Incidence:
6.0-34.0%*
Severity: MODERATE
Onset: EARLY
Photosensitivity Incidence:
>10.0%*
Severity: MILD
Onset: DELAYED
*This is an approximate aggregated range of reported side effects from clinical studies performed on this drug. Your experience with this drug may be different.
Pregnancy & Lactation Information
FIRST Trimester

Class X - Adequate well-controlled or observational studies in animals or pregnant women have demonstrated positive evidence of fetal abnormalities or risks. The use of the product is contraindicated in women who are or may become pregnant.

SECOND Trimester

Class X - Adequate well-controlled or observational studies in animals or pregnant women have demonstrated positive evidence of fetal abnormalities or risks. The use of the product is contraindicated in women who are or may become pregnant.

THIRD Trimester

Class X - Adequate well-controlled or observational studies in animals or pregnant women have demonstrated positive evidence of fetal abnormalities or risks. The use of the product is contraindicated in women who are or may become pregnant.

Lactation

Caution - Not enough information is available to rule out harm to infants when this drug is taken by nursing mothers.


Learning More About
Visit the Drug Summary page where you can:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics
Learn More
Patient Experiences with Tazorac

We want to help you stay educated about the medications you are taking. View other
patient's observations and share your own.

Be sure to consult your health care provider before taking any medications. Other
patient's comments should not be considered medical advice or health care provider
recommendations.